Assessment of Serum Lipid Profiles and Kidney Function in Patients with Type 2 Diabetes
DOI:
https://doi.org/10.46966/msjar.v7i1.390Keywords:
diabetes mellitus (T2DM), lipid profiles, Kidney functionAbstract
The research study was carried out in the Diabetes and Endocrinology Center of Al-Sadr Teaching Hospital in Najaf, Iraq, to examine how the lipid profiles of patients with Type 2 Diabetes have changed since 2025–10–1 to 2026–2–30. The characteristics of 25 healthy subjects (with no health conditions) were compared to the characteristics of the 50 Types 2 Diabetic patients. Glucose levels were assessed and the serum lipid profiles were assessed in terms of TC (total cholesterol), TG (triglycerides), HDL (high-density lipoproteins), LDL (low-density lipoproteins), and VLDL (very low-density lipoproteins), as well as urea and creatinine. The findings showed that the glucose levels in diabetic patients were statistically significantly higher (p < 0.01) than those of the normal group. and the serum lipid profile levels (TC, TG, LDL, VLDL) were also statistically significantly greater (p < 0.01) in the Type 2 Diabetic patients compared to the healthy group. When compared with the control (healthy) group, the HDL measurement of the lipid profile appears significantly less (p < 0.01) for type 2 diabetic patients in a serum sample. Additionally, type ii diabetic patients demonstrated very high levels (p < 0.01) of both urea and creatinine concentrations (measured via blood draw) compared to non-diabetic control subjects. As such, these data support the proposition that diabetes has an adverse effect on both serum lipid profile and kidney function relative to subjects without diabetes.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Zainab Abdul Abbas Nasser, Hadeel Mohsen Abbas, Eman Habib kadhom
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
